Effectiveness of the Lilly Connected Care Program in Improving Glycemic Management Among Patients With Type 2 Diabetes in China: Retrospective Real-world Study

Benli Su   ^{1 *} , MD ;   Yu Chen   ^{2 *} , MD ;   Xingping Shen   ^{3 *} , MD ;   Jianchao Guo   ² , MD ;   Yuchen Ding   ⁴ , PhD ;   Xiao Ma   ⁴ , PhD ;   Yuxin Yang   ⁴ , MD ;   Dongfang Liu   ⁵ , MD

¹ Department of Endocrinology, The Second Hospital of Dalian Medical University, Dalian, China

² Department of Endocrinology, The Second Hospital of Tianjin Medical University, Tianjin, China

³ Department of Endocrinology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China

⁴ Lilly Suzhou Pharmaceutical Co Ltd, Shanghai, China

⁵ Department of Endocrinology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China

*these authors contributed equally